Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Gill

Showing results (101-110 of 443) with videos related to

Pageof 45
Sort By:
AIDS Patient Care and Stds|December 9, 2010
Domestic violence screening: prevalence and outcomes in a Canadian HIV populationReed A C Siemieniuk, Hartmut B Krentz, Jessica A Gish, et al.
AIDS (London, England)|May 25, 2021
Predictive variables for peripheral neuropathy in treated HIV type 1 infection revealed by machine learningWei Tu, Erika Johnson, Esther Fujiwara, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|December 13, 2017
Associations between Depressive Symptomatology and Neurocognitive Impairment in HIV/AIDSSarah Tymchuk, Daniela Gomez, Noshin Koenig, et al.
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|October 12, 2002
Outpatient parenteral antibiotic therapy: evolution of the Calgary adult home parenteral therapy programKevin B Laupland, M John Gill, Linda Schenk, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|April 13, 2002
Slowing the progression of chronic renal insufficiencyMarcello Tonelli, John Gill, Sanjaya Pandeya, et al.
Journal of Clinical and Experimental Neuropsychology|July 25, 2015
Decision making under explicit risk is impaired in individuals with human immunodeficiency virus (HIV)Esther Fujiwara, Sara E Tomlinson, Scot E Purdon, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|August 21, 2018
Evaluation of laboratory disturbance risk when adding low-dose cotrimoxazole for PJP prophylaxis to regimens of high-grade glioma patients taking RAAS inhibitorsRoland Coppens, Johanna Yang, Sunita Ghosh, et al.
Journal of Neurovirology|December 7, 2018
Empiric neurocognitive performance profile discovery and interpretation in HIV infectionDaniela Gomez, Christopher Power, M John Gill, et al.
AIDS (London, England)|November 14, 2008
The effect of antiretroviral treatment of different durations in primary HIV infectionNikos Pantazis, Giota Touloumi, Philippe Vanhems, et al.
AIDS Care|February 2, 2016
Maintaining the continuity of HIV-care records for patients transferring care between centers: challenges, workloads, needs and risksM John Gill, Meagan Ody, Tarah Lynch, et al.
Pageof 45

Showing results (101-110 of 443) with videos related to

Sort By:
Pageof 45
AIDS Patient Care and Stds|December 9, 2010
Domestic violence screening: prevalence and outcomes in a Canadian HIV populationReed A C Siemieniuk, Hartmut B Krentz, Jessica A Gish, et al.
AIDS (London, England)|May 25, 2021
Predictive variables for peripheral neuropathy in treated HIV type 1 infection revealed by machine learningWei Tu, Erika Johnson, Esther Fujiwara, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|December 13, 2017
Associations between Depressive Symptomatology and Neurocognitive Impairment in HIV/AIDSSarah Tymchuk, Daniela Gomez, Noshin Koenig, et al.
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|October 12, 2002
Outpatient parenteral antibiotic therapy: evolution of the Calgary adult home parenteral therapy programKevin B Laupland, M John Gill, Linda Schenk, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|April 13, 2002
Slowing the progression of chronic renal insufficiencyMarcello Tonelli, John Gill, Sanjaya Pandeya, et al.
Journal of Clinical and Experimental Neuropsychology|July 25, 2015
Decision making under explicit risk is impaired in individuals with human immunodeficiency virus (HIV)Esther Fujiwara, Sara E Tomlinson, Scot E Purdon, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|August 21, 2018
Evaluation of laboratory disturbance risk when adding low-dose cotrimoxazole for PJP prophylaxis to regimens of high-grade glioma patients taking RAAS inhibitorsRoland Coppens, Johanna Yang, Sunita Ghosh, et al.
Journal of Neurovirology|December 7, 2018
Empiric neurocognitive performance profile discovery and interpretation in HIV infectionDaniela Gomez, Christopher Power, M John Gill, et al.
AIDS (London, England)|November 14, 2008
The effect of antiretroviral treatment of different durations in primary HIV infectionNikos Pantazis, Giota Touloumi, Philippe Vanhems, et al.
AIDS Care|February 2, 2016
Maintaining the continuity of HIV-care records for patients transferring care between centers: challenges, workloads, needs and risksM John Gill, Meagan Ody, Tarah Lynch, et al.
Pageof 45